0001209191-20-054929.txt : 20201015
0001209191-20-054929.hdr.sgml : 20201015
20201015174412
ACCESSION NUMBER: 0001209191-20-054929
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201013
FILED AS OF DATE: 20201015
DATE AS OF CHANGE: 20201015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EHRLICH JASON
CENTRAL INDEX KEY: 0001754049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38682
FILM NUMBER: 201242238
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kodiak Sciences Inc.
CENTRAL INDEX KEY: 0001468748
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270476525
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 650-281-0850
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: Oligasis, LLC
DATE OF NAME CHANGE: 20090721
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-13
0
0001468748
Kodiak Sciences Inc.
KOD
0001754049
EHRLICH JASON
2631 HANOVER STREET
PALO ALTO
CA
94304
0
1
0
0
See Remarks
Common Stock
2020-10-13
4
M
0
5000
10.29
A
47843
D
Common Stock
2020-10-13
4
S
0
5000
75.00
D
42843
D
Stock Option (Right to Buy)
10.29
2020-10-13
4
M
0
5000
0.00
D
2028-08-29
Common Stock
5000
367575
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
Chief Medical Officer and Chief Development Officer
/s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich
2020-10-15